Skip to main content
ERAS logo

ERAS · Erasca, Inc. · Metrics

Track ERAS — free
$13.61 -0.61 (-4.29%) At close · Nov 20 Q4 2023 earnings call transcript
Market Cap
$4.78B
Shares
350.96M
Volume · Nov 20 11.07M Avg daily vol (3M) 5.23M

ERAS metrics

71 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$13.61
Market cap
$4.78B

Price action

23 metrics
Price change (1W)
-13.1%
Price change (30D)
-3.1%
Price change (3M)
-22.8%
Price change (6M)
+21.1%
Price change (YTD)
+265.9%
Price change (1Y)
+389.6%
Trailing year
Price change (5Y)
-24.5%
52-week high
$22.47
52-week low
$2.78
Change from 52-week high
-39.4%
Change from 52-week low
+389.6%
Annualized volatility
102.7%
Annualized volatility (3M)
70.4%
Implied volatility (30D)
134.8%
IV rank (1Y)
45.4
IV percentile (1Y)
86.7
Beta
1.7
RSI (14D)
42.7
Price vs SMA 50
-7.8%
Price vs SMA 200
-11.2%
Avg volume (3M)
5.23M
Relative volume
2.1
Average dollar volume
$79.82M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
350.96M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
5.2
reciprocal yield 19.2%
FCF yield
-2.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-05-08

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$327.65M
Net income (TTM)
−$307.94M
Trailing 12 months
Diluted EPS (TTM)
$-0.99
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.06
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-1.00
Operating cash flow per diluted share (TTM)
$-0.35
Free cash flow per diluted share (TTM)
$-0.35
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$0.42
Stock compensation per diluted share (TTM)
$0.11
Book value per share
$2.61

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+21.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-33.6%
Return on assets
-30.8%
Debt / equity
0.0
Current ratio
14.9
EBITDA (TTM)
—
Free cash flow (TTM)
−$109.24M
Quick ratio
14.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$643.70M
Latest balance sheet
Cash & equivalents
$118.96M
Total assets
$998.94M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$109.11M
Capital expenditures (TTM)
$132,000
R&D (TTM)
$133.60M
SG&A (TTM)
—
Stock compensation (TTM)
$35.82M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
272
13F filer change QoQ
+15
Institutional ownership
93.2%
Conviction holders (share of 13F filers)
4.8%
Crowding (high-turnover and private-fund holders)
50.0%
Private-fund adviser ownership
47.5%
Active holders' share change QoQ
+16.3%
Holder tenure
9.4
Price vs estimated holder cost
+54.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
11.3%

Short interest

3 metrics
Short interest
10.6%
Latest settlement · 8.9 days to cover
Days to cover
8.9d
Short-squeeze score
77 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1761918 CUSIP 29479A108 13F (30d) 282 filings 260 filers Visit website Investor relations